^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CART-PSMA- TGFβRDN cells

    i
    Other names: TmPSMA 01 CAR-T, PSMA-directed/TGFβ-insensitive CAR-T cells, PSMA-specific/TGFβ-resistant CAR modified autologous T cells, CART-PSMA- TGFβRDN cells, TMUN ONC 001, PSMA CAR-T
    Associations
    News
    Trials
    Company:
    Gilead
    Drug class:
    PSMA-targeted CAR-T immunotherapy, TGF-βRDN-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials